Article
Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5
2023-11-17
Abstract excerpt
By driving monocyte chemotaxis, the chemokine receptor CCR2 shapes inflammatory responses and the formation of tumor microenvironments. This makes it a promising target in inflammation and immuno-oncology; however, despite extensive efforts, there are no FDA-approved CCR2-targeting therapeutics. Cited challenges include the redundancy of the chemokine system, suboptimal properties of compound candidates, and speci...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2c9da849-9819-5903-ac87-cb88ad6a20b7
- DOI
- 10.1101/2023.11.15.567150
